Podcasts about physicians

Five years after COVID-19 upended the world, the debate over where the virus came from is far from over. Physician-scientist and author of “The Code as Witness” Dr. Steven Quay joins us to explain why he believes the strongest evidence for a lab leak isn't hidden in government files—it's written into the genetic code of the virus. He lays out the genomic clues behind his case, weighs in on gain-of-function research, and argues what must change to prevent the next pandemic. Get the facts first with Morning Wire.- - -Ep. 2864- - -Wake up with new Morning Wire merch: https://bit.ly/4lIubt3- - -Today's Sponsors:Fast Growing Trees - Visit https://fastgrowingtrees.com to get 20% off your first purchase when using the code WIRE at checkout.Vanta - Whether you're a fast-growing startup or a global enterprise, Vanta is here to help you automate your security and compliance, and earn and prove trust. Get started today at https://vanta.com/morningwire- - -Privacy Policy: https://www.dailywire.com/privacymorning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, shares insights on the current state of private equity investment in physician practice management, the specialties attracting the most interest, and the operational factors shaping today’s healthcare transactions.

Men account for higher rates of nearly all major chronic diseases, but nearly two-thirds admit that they avoid going to the doctor for as long as possible. Physicians warn that once men enter their 40s, routine screenings become essential for spotting problems before preventable conditions turn life-threatening. June is 'Men's Health Month', and the Department of Health and Human Services wants raise awareness on growing concerns over low testosterone and mental health issues in men. FOX's Eben Brown speaks with Adm. Brian Christine, MD, Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS), who says men need to be open and honest about their health concerns. Click Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To Follow 'The FOX News Rundown: Evening Edition' Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, shares insights on the current state of private equity investment in physician practice management, the specialties attracting the most interest, and the operational factors shaping today's healthcare transactions.

This episode is sponsored by…NCH:Set up an LLC to protect your investments! – https://nchinc.com/rtrBLUPRINT HOME LOANS:Get pre-approved with one of RTR's preferred lenders at - https://bluprinthomeloans.com/renttoretirement/ ROI Property Group:If you are interested in direct lending with ROI Property Group, give Rob Fuller a call at 707-365-6891 to learn more. 12-24 month loan options are available. Let him know that Rent To Retirement sent you! - https://www.roipropertygroup.com/rtrCan a busy physician with a demanding career and two young children realistically build a rental property portfolio? In this episode of the Rent To Retirement Podcast, host Matthew Seyoum sits down with Rent To Retirement investor Colin to discuss how he went from exploring Airbnb investments to owning two long-term rental properties—and preparing for his next acquisition. Colin explains why the operational demands of short-term rentals did not fit his lifestyle, how turnkey real estate helped him invest outside his local market, and why having an experienced team made his second purchase dramatically easier than his first.

This week, we discuss a promising step toward a functional cure for chronic hepatitis B, first-line pulsed field ablation for persistent atrial fibrillation, reducing the demand for transfusion in surgery, treatment for rifampicin-resistant tuberculosis, and a decade-long look at CAR T-cell therapy outcomes. We review peanut allergy and discuss a case of a man with leg weakness, pain, and weight loss; Perspectives explore GLP-1 access, air-quality policy, and the human realities of homelessness.

What if you could get back fifteen hours of your work week without seeing a single extra patient?In this special episode, recorded live in a breakout room workshop following the California DPC Summit, Justin Lam, CEO of Cool Blue VA, sits down with a room full of physicians to talk about getting real help in your practice and in your life. Dr. Maryal Concepcion opens by sharing her own experience working with a virtual assistant she found through Cool Blue VA, then hands the room over to Justin.Justin walks through the questions so many physicians sit with when building a Direct Primary Care practice. Research shows only twenty-seven percent of a physician's time goes to direct patient care, while nearly half disappears into desk work and admin. Justin breaks down how to change that.You will hear:The "only you" test for deciding what to delegate and what to keep. If someone else can do it, it probably should not be on your plate.Why fifty percent is the right time to hire, not one hundred percent, and how waiting too long leads to rushed decisions and the wrong hire.How to design your ideal role before you ever start looking, including the top tasks to hand off, the tools your assistant will use, and how to measure success.The real difference between a local medical assistant and a virtual assistant, and what each one is best suited for. Local staff handle high-touch, in-person, revenue-generating work. Virtual assistants cover the inbox, scheduling, prior authorizations, records, specialist coordination, billing, and more.Practical hiring tools you can use today, from spelling and math checks to typing tests and strength assessments.The honest back and forth with physicians in the room, who ask about charting support, inventory, time zones, vacation coverage, billing by the minute, and even using a virtual assistant as an executive assistant for your home life.Whether you have a full panel or you are still mapping out your first month open, there is something here worth holding onto.Ready to grow your practice with the right support? Start here: coolblueva.com/dpcgrowA quick note on the audio. Because this was captured in a smaller breakout space, the sound gets tricky in spots. Thank you in advance for your patience with it.Connect with My DPC Story: Listen, subscribe, and explore more at the My DPC Story podcast and media platform.Support the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOADBecome A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Dr. Darien Sutton MD MBA — is an emergency physician and ABC News medical correspondent. He joins me for a conversation about sleep, stress, and why doctors need to be fighting health misinformation online. Darien is candid about the healthy sleep habits that residency made difficult, about the orthopedic surgeon who taught him more about stress than medical school ever did, and why he believes physicians can't sit out the misinformation epidemic. We get into food noise, GLP-1 medications, and why obesity is a chronic condition — not a moral failure.  Read more in Men's Health. Follow Darien on Instagram. Check out his Tik Tok vids. ▶ Subscribe on YouTube @resaelewissmd  New Visible Voices episodes on Wednesdays.

In this Season 6 executive summary episode of the Wealth Planning for the Modern Physician Podcast, host David Mandell reflects on the major themes, conversations, and lessons shared throughout the season. David explains the structure of the podcast's academic calendar format and previews the upcoming Summer Rewind series, which revisits standout episodes from prior seasons. He then walks listeners through each episode of the season, highlighting important insights and lessons from all 20 episodes. By summarizing each episode from the season, this episode serves as both a roadmap for listeners looking to revisit episodes they may have missed and a reminder of the practical strategies, red flags, and opportunities physicians should consider as they navigate modern medical careers. Insights Covered in Season 6: Private practice compensation models are evolving to better align with the priorities of younger physicians entering medicine.  Entrepreneurship in healthcare can create significant opportunities, but it also introduces operational, financial, and emotional risks. Asset protection planning requires ongoing maintenance and discipline rather than a one-time legal setup. Artificial intelligence is already improving workflow efficiency and reducing administrative burden in clinical practice. Physician burnout often requires both operational changes and personal reinvention strategies to address effectively. Healthcare mergers, acquisitions, and private equity activity continue to reshape the physician practice landscape. Financial literacy and business education can dramatically improve a physician's ability to make informed career decisions. Peer review processes and workplace conflicts can have major professional and financial consequences if handled improperly. Real estate investments can be beneficial for physicians, but leverage and market timing carry meaningful risks. Strong mentorship, networking, and community support remain essential throughout every stage of a physician's career. Learn more, including additional show notes, links, and detailed key takeaways, by visiting physicianswealthpodcast.com. Click here to get your FREE copy of our latest book, Wealth Strategies for Today's Physician!

On this episode of KeyLIME+, Adam sits down with 'the medical futurist', Dr. Bertalan Meskó, to explore what it means to prepare for the future of medicine in an era currently shaped by artificial intelligence. Using prompt engineering as a starting point, the conversation moves beyond the technical to focus on a deeper shift in how clinicians adapt in the face of rapid change. Together, they examine the risks of over-reliance on AI, the pitfalls of bold predictions, and the enduring role of human connection in healthcare. The discussion ultimately reframes AI not as the destination, but as a tool for helping clinicians prepare for what lies ahead.  Length of Episode: 39:23  Resources to check out:  Meskó B. Prompt Engineering as an Important Emerging Skill for Medical Professionals: Tutorial. J Med Internet Res. 2023 Oct 4;25:e50638.    Episode 38 AI and Emerging Skill Gaps: Deskilling, Never-Skilling, Mis-Skilling – and What Educators Can Do About It All  Contact us: keylime@royalcollege.ca     Follow: Dr. Adam Szulewski https://x.com/Adam_Szulewski           

In this episode of Future of Fitness, host Eric Malzone sits down with Dr. Tania Elliott—board-certified physician, three-time Chief Medical Officer, and a leading voice in healthcare innovation—to break down the collision course between the fitness industry and the future of preventative health. Dr. Elliott doesn't hold back: she calls out the fitness world for being too intense or too dainty, challenges the gatekeeping role of primary care, and paints a vivid picture of what the health club of the future should really look like. From the over-reliance on protocols and biohacking to the untapped power of community, nutrition, and strength training for women, this conversation is a bold, no-BS look at how fitness can evolve from a destination into a way of life. If you're ready to rethink everything you know about health, wellness, and the role of gyms in healthcare, this one's for you.

In this Q&A episode of our pediatric neurology series, we answer listener questions about some of the most rapidly evolving areas in neurology and genetics. The discussion begins with the relationship between child abuse evaluations and Brief Resolved Unexplained Events (BRUE), including important considerations when assessing infants with unexplained symptoms.Host Paul Wirkus, MD, FAAP and guest Josh Bonkowsky, MD then explore the neurologic basis of developmental disorders and the growing role of advanced diagnostics such as genome sequencing and MRI. Our guests discuss how these tools can provide valuable insights into underlying conditions and increasingly influence treatment decisions and long-term care planning.The conversation also examines the complex relationship between genes, brain development, and the symptoms children experience. As genetic testing becomes more widely available, we consider the promise of gene therapy, the emerging field of precision medicine, and realistic timelines for translating these advances into everyday clinical practice. Finally, we discuss the benefits of obtaining a genetic diagnosis-even when a cure is not yet available-including connecting families with resources, reducing isolation, informing future care decisions, and the potential expansion of newborn screening programs as genetic therapies continue to develop.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Send us Fan MailWhat if the biggest threat to your medical practice isn't declining reimbursement, staffing shortages, rising expenses, or even physician burnout?What if it's the culture you've unintentionally created?That may sound dramatic, but after working with hundreds of physician practices across the country, I've seen something over and over again. Practices spend enormous amounts of time worrying about external threats while overlooking the internal dynamics that are quietly draining productivity, increasing turnover, damaging morale, and ultimately affecting patient care.Every day, medical practices lose talented employees, valuable revenue, and patient trust because teams spend more time assigning blame than solving problems.And here's the difficult truth. Most toxic workplace cultures don't begin with bad people. They begin with good people operating inside broken systems.Today we're going to talk about why blame culture develops in healthcare organizations, the hidden costs that most leaders never calculate, how the infamous front-office-versus-back-office battle hurts everyone involved, and most importantly, how you can transform your practice into a culture built on accountability, transparency, and continuous improvement.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: https://share.hsforms.com/1FMup6xLPSpeA8hB77caYQwd32sx?hsCtaAttrib=171926995377 Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Promo pricing available now: https://education.healtheps.com/offers/Ry3zfLYp/checkout?coupon_code=PHYSEDGE3000 Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/    

Send us Fan MailWhen was the last time you actually saw your own doctor? If you just cringed a little, you are exactly who this episode is for.I take care of a lot of physicians in my practice, and I have heard every version of the story: self-prescribed thyroid meds, skipped physicals, and a very impressive collection of coping strategies that are working just well enough to keep going. I get it because I live it too. But there are things I say to my patients, including my physician patients, that I want to say directly to you.In this episode I walk through 10 things I would tell you if I was sitting across from you in the exam room. Some of them are the basics you already know and are not doing. Some of them are the harder truths about rest, stress, and the lie we have all been sold about what it means to handle everything. And one of them is about Botox, because we need to have that conversation.This is not a lecture. This is what peer-to-peer honesty sounds like when your doctor actually knows what your life is like.Hit play. You have earned this one.If this resonates and you want support actually living it, let's talk. Schedule a free discovery call here: https://calendly.com/healthierforgood/coaching-discovery-callConnect with Megan:Instagram: @MeganMeloMDWebsite: healthierforgood.comEmail: megan@healthierforgood.com Support the showTo learn more about my coaching practice and group offerings, head over to www.healthierforgood.com. I help Physicians and Allied Health Professional women to let go of toxic perfectionist and people-pleasing habits that leave them frustrated and exhausted. If you are ready to learn skills that help you set boundaries and prioritize yourself, without becoming a cynical a-hole, come work with me.Want to contact me directly?Email: megan@healthierforgood.comFollow me on Instagram!@MeganMeloMD

Gaddiel Rios, M.D., is the Primary Care Physician at MED360 by Monument Health in Rapid City. Dr. Rios tells Mark Houston about his history of military service and his medical career, including how he was initially drawn to technology and engineering before moving into medicine. As the only Physician at MED360, Dr. Rios covers a wide range of patients who have direct access without many of the intermediary complications that can be associated with Primary Care. Watch or listen to find out if MED 360 is for you. Hosted on Acast. See acast.com/privacy for more information.

What happens when a lifelong emergency physician steps back from clinical practice and dedicates himself to helping other doctors navigate the impossible job of medicine?  In Part 1 of a two-part episode, Dr. Rob Orman joins Dr. Andrea Austin to share his remarkable path, from documenting mass casualty events to becoming a technical advisor for the hit HBO series The Pit, and ultimately building a coaching practice that helps physicians create meaningful change in their behavior and careers. Together they discuss the importance of awareness, the space between stimulus and response, cognitive empathy, and why art and storytelling may be powerful vehicles for transforming healthcare. Rob also opens up about his own career struggles and the deep fulfillment he finds in one-on-one behavioral coaching. They discussed: How documenting mass casualty events led to advising on The Pit The career shift from full-time clinician and educator to physician coach Why “not everyone thinks like you do”, and the power of cognitive empathy Building awareness and creating the pause between stimulus and response Behavioral coaching for physicians on performance plans or struggling with reactivity The role of storytelling and art in driving healthcare change Lessons from burnout, skill decay, and career transitions

Many leaders might talk about inspiring others - but Jon Naylor walks the walk. With a career spanning military aviation medicine, NHS practice, and ultra-running adventures, his story reveals the unbreakable link between mental resilience, physical endurance, and leading by example. Discover how his experiences in the military, in the mountains, and in crisis situations teach a timeless lesson: true leadership is forged through stepping into the challenge, not just planning for it.keywordsleadership, running, ultra marathon, resilience, mental health, military, medicine, high altitude, training, personal developmentkey  topicsLeadership in military and medical fieldsThe mental and physical benefits of runningTraining for ultra marathons and mountain climbingThe role of resilience and perseveranceUsing running as a tool for mental health and problem-solvingLinksUltra Trail de Mont Blanc - https://www.ultratrailmb.com/Paddy Buckley Round - https://paddybuckleyround.co.uk/And Jon's LinkedInhttps://uk.linkedin.com/in/jon-naylor-b011b39

Today on the Christian History Almanac, we head to the mailbag to answer a question about the (a?) Patron Saint of Physicians. Show Notes: Give to the June 1517 Podcast Network Fundraiser! Learn more about the 1517 Podcast Network Fundraiser 1517 Podcasts 1517 on YouTube 1517 Podcast Network on Apple Podcasts 1517 Events Schedule 1517 Academy - Free Theological Education Germany / Switzerland - Study Tour What's New from 1517: By Water and the Word by Brian Thomas:  Being Family by Dr. Scott Keith  A Reasoned Defense of the Faith by Adam Francisco  Stretched: A Study for Lent and the Entire Christian Life by Dr. Christopher Richmann  The Essential Nestingen: Essays on Preaching, Catechism, and the Reformation More from the hosts: Dan van Voorhis Follow 1517:  Instagram X/Twitter Facebook SHOW TRANSCRIPTS are available: https://www.1517.org/podcasts/the-christian-history-almanac CONTACT: CHA@1517.org Facebook Twitter Audio production by Christopher Gillespie (outerrimterritories.com)

In this episode, Dr. Peter Kim sits down with Troy Eckard, a 41-year oil and gas veteran who says what's happening in the energy market right now is something he has never seen in his entire career. They break down why the Strait of Hormuz crisis is about to hit physicians' wallets harder than most realize, what the major tax advantages in oil and gas are that almost no one is talking about, and why the window to act may be closing faster than you think. If you've been sitting on the sidelines wondering whether oil and gas belongs in your portfolio, this is the episode that might finally answer that question. Tune in! Eckard Enterprises brings this episode to you. Eckard Enterprises, LLC, is a family-owned and operated alternative investment and asset management firm, specializing in mineral rights and the U.S. energy industry. Eckard believes that owning tangible assets is one of the safest, long-term investment strategies available in today's investment climate. Learn more about Eckard Enterprises! Are you looking for a community to encourage you as you begin, or want to accelerate your business to the next level? Then join thousands of physicians who share the same journey of creating their ideal lives through multiple streams of income by joining us in our Facebook communities such as Passive Income Docs and Passive Income MD.

Disclaimer: Today's episode is sponsored by Gelt. Content is for educational purposes only. Not advice. Results discussed have not been vetted. Claims made by the guest have not been verified. The views expressed by the guest do not reflect those of the host or this show.—

Send us Fan MailWhat would it really mean to shorten neonatology fellowship training to two years? In this episode, Ben and co-host Dr. Shetal Shah sit down with three division heads, Dr. Jill Maron (Brown), Dr. Patrick McNamara (University of Iowa), and Dr. Sarah Taylor (Yale), to examine the ABP's proposed changes from the perspective of those who run major academic NICUs. From the operational and financial strain of losing an entire class of third-year fellows, to the erosion of scholarly development, dwell time, and faculty wellbeing, the conversation makes clear that the costs of this proposal go far deeper than the curriculum. How do you staff an 80-bed NICU without junior fellows? Who funds the gap? And what happens to the next generation of academic neonatologists if we train them in isolation from the very experiences that shape their identity as clinicians and scholars?Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

In this episode, Michael Ezzie, MD, President, OhioHealth Physician Group, and Frank Panzarella, Principal, ECG Management Consultants, discuss how healthcare organizations can lead meaningful physician enterprise transformation at scale. They explore the challenges of access, governance, communication, and culture change while sharing practical strategies for sustaining long-term improvement in today's high-pressure healthcare environment.

When Dr. Maggie Kang's nine-year-old daughter was diagnosed with a rare, incurable autoimmune disease, she was the radiologist who first saw the images. What followed was not just the grief of a mother watching her child suffer. It was two years of silent, suffocating guilt built on a story that made no logical sense but felt completely true. In this episode, Dr. Kang talks about the difference between pain and suffering, why doctors are particularly vulnerable to the stories that keep them stuck, and what it actually takes to let those stories go. The insight she shares is one that applies far beyond rare disease diagnosis, and doctors who have ever blamed themselves for a bad outcome will recognize it immediately. Episode Highlights [01:00]: Dr. Kang describes the moment she first saw her daughter's images as a radiologist, and what the following five weeks in hospital looked like for their family. [06:00]: She had tried thinking her way through the guilt for two years before coaching surfaced a belief she had never once said out loud to another person. [11:00]: Dr. Kang explains why this particular belief was so hard to release, and how cultural background, professional identity, and motherhood all collided in ways she had not anticipated. [15:00]: The moment she stopped asking what had gone wrong and started asking a different kind of question entirely set off a chain of events that is still unfolding today. [25:00]: She draws a clear line between pain and suffering that reframes how doctors might think about everything from a difficult diagnosis to a bad clinical outcome. [31:00]: A lobster metaphor that her whole family now uses to talk about growth, uncertainty, and what it actually means to let go of a story that is no longer serving you. Three Key Takeaways 1. Pain is unavoidable. Suffering is the story we add to it. Dr. Kang makes a distinction that sounds simple and lands hard. Pain is the actual experience: a child who is sick, a patient outcome that did not go as hoped, a career that suddenly changes course. Suffering is the additional layer of blame and guilt that doctors quietly construct around that pain, often without ever examining it or saying it aloud. For doctors, who are trained to believe that good outcomes follow from doing everything right, this distinction is particularly important. When things go wrong despite their best efforts, the story they reach for is often the harshest one available. 2. The stories that keep doctors stuck rarely survive being questioned out loud. Dr. Kang spent two years convinced she should have caught her daughter's diagnosis earlier, even though the pediatric presentation of the disease she knew was entirely different from what she had trained on. It was not logic that kept that belief in place. It was shame. Shame keeps stories in the dark, and stories in the dark grow. What coaching gave her was not an answer, but a question: are you sure? That single question, asked with genuine curiosity by someone else, was the beginning of everything that followed. 3. Letting go of a story means tolerating not having one. Dr. Kang uses the lobster as her metaphor, and it is a good one. When a lobster grows, it has to shed its shell and endure a period of complete vulnerability before the new shell forms. The discomfort of that transition is not a sign something is wrong. It is the growth itself. For doctors, releasing a long-held belief about what they should have done or who they should be does not feel like freedom at first. It feels like losing ground. Dr. Kang describes that period honestly and what she found on the other side of it. Guest Bio Dr. Maggie Kang is a TEDx speaker and certified coach who works with mothers navigating life with a child's chronic or rare disease diagnosis. She runs the Lobster Lessons newsletter and advocates for the neuroimmune disease community alongside her daughter Nell at maggiekangmd.com. Would you like to view a transcript of this episode? Click Here Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. Come hang out with me on Facebook or Instagram. Follow me @thechartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.

Interview with Jacob E. Kurlander, MD, MS, author of Multilevel Stewardship Intervention for Use of Anticoagulation-Antiplatelet Therapy, and C. Seth Landefeld, MD, author of Deprescribing Inappropriate Medicines Across a Health System—Can We Improve the Care of Both Patients and Physicians? Hosted by Ilana Richman, MD. Related Content: Multilevel Stewardship Intervention for Use of Anticoagulation-Antiplatelet Therapy Deprescribing Inappropriate Medicines Across a Health System—Can We Improve the Care of Both Patients and Physicians?

While at the recent Navina Ascend user conference, Healthcare IT Today had the opportunity to sit down with three of Navina's customers to learn more about their experience using Navina at their organizations.  Needless to say, the doctors were all candid with their experience with the technology and the impact it was having on their organization.Learn more about Privia Health: https://www.priviahealth.com/Learn more about CVFP: https://www.cvfp.net/Learn more about Summit Medical Group: https://www.summitmedical.com/Learn more about Navina: https://www.navina.ai/Healthcare IT Community: https://www.healthcareittoday.com/

Dr. Lauren’s Story Physician with 16 Fibroids and 5 Miscarriages Gets Her Baby Girl Sixteen fibroids. Five miscarriages. A physician who knew all the statistics and still hit the ceiling. This is the story of Dr. Lauren Teverbaugh-Smith, who went from a body she stopped trusting and a life that kept getting smaller, to a […] The post EP382: Physician with 16 Fibroids and 5 Miscarriages Gets Her Baby Girl: Dr. Lauren’s Story appeared first on Rosanne Austin.

In medicine, we are trained to trust what is hard, measurable, familiar, and structured. We question whether something spacious, nourishing, or beautiful can be meaningful, impactful, and lead to real growth and learning. Many physicians are skeptical of coaching, mindfulness, breathwork, retreats, and yoga as relevant and meaningful learning because they do not resemble traditional medical education. This episode encourages you to reconsider what medicine may have taught you to dismiss. PEARLS OF WISDOM • What medicine sometimes labels as "woo" may simply be unfamiliar, hard to measure, or outside the traditional medical framework. Mindfulness, coaching, yoga, breathwork, retreats, and nervous system regulation can still be rigorous, evidence-informed, and deeply impactful. • Suffering is not required for growth. We often equate exhaustion, discomfort, and over-effort with value, yet real learning is often more accessible when we are rested, regulated, and receptive. • Transformation is not the same as information. Physicians are excellent at consuming information, but lasting change comes from integration, practice, embodiment, and living differently in real time. • Simple practices are not shallow. A breath, a pause, a hand on the heart, a walk, a reflective question, or a meaningful conversation can interrupt old patterns and open space for a different response. • Conditions matter. Safety, spaciousness, beauty, community, nature, reflection, and skilled facilitation can make rigorous inner work more possible, not less credible. Real transformation happens when learning becomes embodied, integrated, relational, and safe.   Reflection Questions Where are we still equating suffering with value, rigor, or meaning? What kinds of learning have given us information without creating the change we were hoping for? Where are we treating something unfamiliar as not credible? What might become possible if comfort, beauty, rest, and spaciousness became part of healing and growth? Stay curious about the places where medicine has taught you to dismiss what you have not yet experienced.  Coaching, retreats, mindfulness, breathwork, yoga, reflection, and community are invitations to relate to ourselves, our work, our patients, and our lives with more presence and sustainability. www.jessiemahoneymd.com www.jessiemahoneymd.com/retreats www.jessiemahoneymd.com/yoga www.jessiemahoneymd.com/mindful-healers-podcast Nothing shared in the Healing Medicine Podcast is medical advice.  

What happens to a family physician when the system that trained him decides he no longer has value? In this deeply personal episode, Dr. Maryal Concepcion hands the introduction to a special guest, then sits down with her husband, Dr. Jeremiah Fillo of Big Trees MD, for an honest conversation about sustainability, not just as a doctor, but as a whole person.Dr. Fillo shares the path from rural Nebraska training under Dr. Tim Blecha (Blay-kee), through residency in Modesto, into a corporate regional medical center that slowly turned the heat up the way you would on a frog in a pot. He talks candidly about the evergreen contract, the exclusivity clause, and the moment he was told to sign or be terminated while his wife was pregnant. He describes being let go and replaced by a non-physician model, the AB 890 reality in California, and the months of uncertainty that followed.This is also a conversation about what comes after the devaluation. Dr. Fillo opens up about how he held onto his sense of self when the system told him he had none, why splitting and stacking firewood mattered as much as any clinical workflow, and how he learned to quiet his "referralologist" training once he joined a Direct Primary Care practice with real time and autonomy. Listeners will hear how DPC reshaped his parenting, his task switching between in-office visits and asynchronous telemedicine, and his perspective on joining an established practice he did not build from scratch.For any physician who has felt like a charge sheet instead of a clinician, this episode is a reminder: the system does not get to decide your worth, and there is real life after fee-for-service.In this episode: How job share became the foundation of a sustainable two-physician family. Why residency training around fee-for-service leaves new physicians blindsided to independent options. What being replaced by a non-physician model does to a person, and how to rebuild. Why rural communities cannot sustain healthcare on a three-day-a-week, hard-to-access model. How Direct Primary Care creates room to practice full scope again and still be present for your kids.About the guest: Dr. Jeremiah Fillo is a family physician at Big Trees MD in Arnold, California, where he practices Direct Primary Care alongside Dr. Maryal Concepcion. He trained at Creighton University School of Medicine and completed residency in Modesto, with additional procedural training at Brodstone Memorial in rural Nebraska.Connect with My DPC Story: Subscribe wherever you listen, leave a review, and share this episode with a physician who needs to hear that there is a sustainable path forward. Have a question or a story of your own? Call the My DPC Story voicemail and you may hear your answer on a future episode.Lean more about Hint Clinical today! Check out CoolBlue VA today at coolblueva.com/dpcgrow VOTE in the 2026 Battle of the Support Stack HERE! Support access to women's healthcare and join us for Fireside Chats for Women's Health in New Orleans! July 17th 7-9 pm. BUY tickets at mydpcstory.com/upcoming-events. If you're interested in donating or sponsoring, email hello@mydpcstory.com Get your copy of the Physician Owner's Planner today at mydpcstory.com/librarySupport the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOADBecome A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

In this episode, Ericka Beeler, MBA, CEO, Beeler Consulting, LLC, shares her journey from frontline healthcare roles to entrepreneurship, discussing the firm's work supporting rural hospital turnarounds and helping independent physicians launch and grow successful practices.

Pastor Kurt takes a deep dive into Matthew 9:1-13 where Jesus shows His authority not only to heal bodies, but to forgive sins and transform lives. By healing the paralytic, calling Matthew, and eating with sinners, He reveals that He came for the spiritually sick, not the self-righteous. The passage highlights both the power of Christ to pardon and the mercy of Christ to pursue those society overlooks.

In this episode, Amber Walsh, Partner at McGuireWoods LLP, discusses the evolving healthcare private equity landscape, investor interest across physician specialties, the continued growth of ASC strategies, and more.

In this episode, Amber Walsh, Partner at McGuireWoods LLP, discusses the evolving healthcare private equity landscape, investor interest across physician specialties, the continued growth of ASC strategies, and more.

Paul J. Molinaro, M.D., J.D. is a California mediator and arbitrator who brings a somewhat unusual perspective to dispute resolution. He has practiced medicine for many years before becoming a lawyer and now focus on mediating medical malpractice, personal injury, and other complex injury cases.Paul has worked on both sides of the medicine–law divide, he often speaks about how physicians, lawyers, and litigants actually think during high-stakes disputes, and how cognitive bias, risk perception, and communication styles can make or break a mediation. He believes that perspective can be useful for attorneys, mediators, and anyone interested in conflict resolution.By way of background, He is a physician since 1991 and a lawyer since 2006, and has recently completed advanced dispute-resolution training at Pepperdine's Straus Institute. He has currently mediate cases involving medical and bodily injury issues and speak to legal audiences about mediation and negotiation.______________________________Paul J. Molinaro, M.D., J.D.Mediator, Arbitrator, Attorney at Law, Physician, Real Estate Broker______________________________MD JD Dispute Resolution4160 Temescal Canyon Road, Suite 306Corona, CA 92883(951)520-9684 Ext. 102paul@mdjddisputeresolution.com www.mdjddisputeresolution.comSCHEDULE YOUR MEDIATION: https://ichatmediation.com/calendar/OFFICIAL BLOG: https://ichatmediation.com/podcastOFFICIAL YOUTUBE: http://www.youtube.com/ichatmediationOFFICIAL LINKEDIN: https://www.linkedin.com/company/ichat-mediation/ABOUT MATTHEW BRICKMAN:Matthew Brickman is a Supreme Court of Florida certified county civil family mediator who has worked in the 15th and 19th Judicial Circuit Courts since 2009 and 2006 respectively. He is also an appellate certified mediator who mediates a variety of small claims, civil, and family cases. Mr. Brickman recently graduated both the Harvard Business School Negotiation Mastery Program and the Negotiation Master Class at Harvard Law School. 

Disclaimer: Today's episode is sponsored by Gelt. Content is for educational purposes only. Not advice. Results discussed have not been vetted. Claims made by the guest have not been verified. The views expressed by the guest do not reflect those of the host or this show.—

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Nicholas Grosso, President, The Centers for Advanced Orthopaedics. He discusses the launch of MedVanta, the importance of physician ownership in healthcare operations and technology, and how strong teams help organizations navigate rapid change while preserving long-term value.

“B” is for Brown, Lucy Hughes (1863-1911). Physician.

Last 4 days before regular tickets sell out at AI Engineer World's Fair - this is the single biggest gathering of AI Engineers, Founders, Leaders, and Researchers in the world. Attendees get >$5000 worth of sponsor credits and talk tracks are looking FANTASTIC. Join us!The AI scaling debate always focuses on the question of “how do we get more GPUs?” but the better question may be: how do we make the most of ones we already have.The fact that a frontier lab like xAI could be running at sub-10% MFU (Model FLOPs Utilization) is just a hint at what the real problem may be.For context, older frontier-scale training runs were already much higher than 10%. GPT-3 was around 21% MFU. Gopher was around 32%. Megatron-Turing NLG was around 30%. PaLM reached around 46%. And our guest Anjney says best-in-class MFU today is closer to 60–70%.It's not necessarily that xAI is uniquely incompetent (it's clear they have talented folks) but rather the priorities may be flipped in the GPU arms race.While GPU access is a bottleneck, simply increasing CapEx won't automatically translate to better models as frontier AI is increasingly a systems problem: scheduling, utilization, networking, kernels, frameworks, data pipelines, parallelism, cluster reliability, and the thousand small decisions that determine whether your theoretical FLOPs become real training progress.From building Discord's developer platform and backing frontier AI companies like Anthropic, Mistral, Black Forest Labs, and Periodic Labs to now building AMP's independent compute grid, Anjney Midha has spent years close to the real bottlenecks of AI scaling. In this episode, Anjney joins swyx at Periodic Labs to unpack why the AI race is not just about buying more GPUs, why 95% utilization would have been considered an outage at Google, and why the next era of AI infrastructure has to be more aligned, more efficient, and more responsible.We go deep on AMP's vision for a compute grid that makes FLOPs flow like megawatts, the difference between full-stack AI labs and horizontal pooling, why AI data centers need community buy-in, and how compute markets could evolve into something closer to an independent system operator. Anjney also explains why DeepMind's unpublished research points to a market failure, why end-of-life prediction remains one of the most important AI applications he has thought about for fourteen years, and why “output maxing” may become a new discipline for frontier systems.We also discuss Anthropic's culture, why “luck favors the prepared mind” in coding models, how Claude cracked coding, why too much capital too early can make AI labs fragile, what Periodic Labs is trying to do with science and superconductors, why great researchers can become great CEOs, and why Silicon Valley is both deeply missionary and deeply mercenary.We discuss:* Why 95% utilization was considered an outage at Google* Why AI infrastructure waste compounds at frontier-lab scale* Why “move fast and break things” does not work for AI data centers* How data center backlash, power grids, and community incentives shape AI scaling* AMP's vision for making FLOPs flow like megawatts* Why compute needs an independent system operator* How interruptible demand and dynamic prioritization worked inside Google* Why DeepMind research hoarding creates negative externalities* AMP's 1.2GW base-load ambition and the need for 6GW of spike capacity* Why end-of-life prediction could become one of AI's most important healthcare applications* Frontier Systems, output maxing, and full-stack alignment* Why APIs and abstraction layers become lossy as organizations scale* Superconductors, standards, and the dream of lossless systems* SF Compute, open protocols, and the future of compute marketplaces* Why non-NVIDIA chips can still benefit from NVIDIA's reference architecture* Trust boundaries and why chip startups need visibility into future model architectures* Why VCs often underestimate researchers as CEOs* Scientists as star athletes of the mind* Why great CEOs need to be confrontational up and down the stack* Why leading the frontier matters more than “winning”* How Anthropic cracked coding* Why culture is fragile, not a permanent moat* Why hardship was a feature, not a bug, for Anthropic* Why Anthropic's P0 was coding from day one* Periodic Labs, physics as the constraint, and technical reality* Silicon Valley mercenaries, missionary teams, and what happens after a breakthroughAnjney Midha* LinkedIn: https://www.linkedin.com/in/anjney* X: https://x.com/AnjneyMidhaAMP PBC* Website: https://amppublic.com/* X: https://x.com/amppublicTimestamps00:00:00 Introduction00:00:09 Why AI Compute Is Being Wasted00:03:17 Responsible Infrastructure and Data Center Backlash00:06:07 AMP Grid: Making FLOPs Flow Like Megawatts00:12:41 Foundry, Frontier Labs, and Research Hoarding00:14:42 Gigawatt-Scale Compute and End-of-Life Prediction00:24:08 Frontier Systems, Output Maxing, and Alignment00:27:38 Compute Markets, SF Compute, and Non-NVIDIA Chips00:32:57 Trust Boundaries, Co-Design, and Researcher CEOs00:38:17 AI Coachella and First-Principles Thinking00:42:43 Leading vs Winning in Frontier AI00:45:54 How Anthropic Cracked Coding00:48:25 Culture, Hardship, and Anthropic's P000:54:03 Periodic Labs, Physics, and Silicon Valley Mercenaries00:56:26 Rishi Valley, Singapore, and Money as a Measure00:58:47 Closing ThoughtsTranscriptIntroduction: Anjney Midha, AMP, and Compute WasteSwyx [00:00:00]: We're in Periodic Labs with Anjney Midha, CEO, founder of AMP. Welcome.Compute Utilization: Node Allocation, MFU, and AlignmentAnjney [00:00:09]: Thanks for having me. At Google, there are two types of utilization usually, right? That you're measuring in these clusters. One is node allocation, and then the other's MFU. Node utilization is usually like what percentage of cards in the data center are just, used, and that, if it's not at, 95%-Swyx [00:00:29]: There is no excuseAnjney [00:00:29]: There's no excuse, right? I think 95% at Google, which is where my co-founder, Seb, came from, he built the Borg, PBorg/GQM scheduler at Google, and there I think 95% was considered an outage, so 96% node utilization is, should be standard. And most single-tenant clusters are not running at that. So that's one. And then MFU should be, I would say the best in class today is somewhere between 60 and 70%. I think this is a leadership question, right? Fundamentally it's an alignment question, which is are the people who are funding the cluster and then deploying the cluster actually aligned? And sometimes theoretically they are, but in practice the number of people in the chain, the supply chain between, the capital and all the way to whoever's managing the cluster and then whoever's measuring what the output is, are just so many, degrees of separation away that, the, The Have you ever heard the radian metaphor, which is at the beginning of an arc, if you have two arcs that are two lines that are just off by a few degrees, that-Swyx [00:01:33]: It spreads outAnjney [00:01:34]: It spreads out, right? Or at scale. And I think what's happening is a lot of cluster implementations and infrastructure, a lot of frontier labs and other teams, that's what's happening, is they're, they initialize the plan, which is kind of like North Star with a team that wants to do good, but then they're, required to scale so fast instead of iteratively that the wastage just compounds really fast at scale. And so I think we know the answer, which is just do iterative bring ups. If you spend time with people who've been in the semiconductor industry or the DSN industry for a long time, this is not new, and I don't think AI should be an excuse. Sure. Something What is new? Okay. We have a lot of new capabilities, but that doesn't mean just abandon common sense. Common sense should always be in fashion. ? AI scaling doesn't change the in fact, if anything, AI scaling should be putting a premium on the value of common sense and infrastructure because the margin of error now is so much lower and the costs of wastage are so much higher. And the cost of wastage, by the way, is not just economic. I'm, obviously I'm, I'm an investor, or I'm an investor by background. Over the last few years now we're running an AI infrastructure business called, AMP. And I think that it's okay to say this time is different on the capabilities front. We are genuinely getting capabilities at, of the, of a kind we haven't had before. That doesn't give you an excuse to say this time is different for everything, especially infrastructure. So look, I love the hacker mindset and the hustler mindset. Now, that's great for the startup mindset, but you remember this moment where Zuck went from saying, “Move fast, break things” to, move-Responsible Infrastructure and Data Center BacklashSwyx [00:03:10]: Fast and stable infrastructureAnjney [00:03:11]: Move fast with stable infrastructure. I think now we need to move fast with, responsible infrastructure. People are going to ask where the impact is. There was a really In our class yesterday, Scott Nolan, who's the founder of General Matter, came by at Stanford to speak about energy bottlenecks. And he had a phenomenal idea. He said, “if you look at the marginal unit economics of compute per hour,” he goes, “let's call it, $4 an hour. If you're having to bring up a new data center in a new community, why not just say we're going to charge 4.50 an hour, and that marginal impact or that marginal increase, we just literally take that and give it to the local community as cash?” I can tell you as a customer of that compute, I would love that. I'd be happy to pay an additional 50 cents per hour at scale.Swyx [00:03:57]: Wow. Yeah.Anjney [00:03:58]: Because if that means the public benefit is so clear to the communities that the data centers are coming up in, I'm going to feel like that compute is much more reliable. Up to 20% of all data centers this year in the US, my understanding is are at risk.Swyx [00:04:13]: Of community backlash?Anjney [00:04:14]: Correct. Of not getting the community support they need to get brought up.Swyx [00:04:19]: Wow. That's a huge number.Anjney [00:04:20]: Yeah. Now, we, I think we should dig into what that number is. I think it's a little bit of overstated. These things can get over-reported, but it-Swyx [00:04:27]: They don't just care about jobs. They care about all the other stuff around it, right? They care about power grid, they care about environments-Anjney [00:04:33]: Power grid, permitting, and so on. And imagine I think if you said there's a new AI deal. If we're bringing up a data center in your community, we're actually going to reduce the cost of your electricity bill. Okay, now we're talking. Right? The community's going, “Okay. Now this is a deal. I feel like a partner in this.” Right now that's not happening. There will be audits, there will be investigations, and when the, when the regulators come, I don't know when it's going to be, the folks who are moving fast and breaking things in the name of AI progress better be prepared. That's certainly not how we're procuring compute. Or we're, we're trying as much as we can to work with partners who have long-term track records. Many of whom, by the way, are not, AI providers. I think this whole idea of neoclouds being somehow this new category is a lot of marketing speak. There are really good, reliable, trusted data center providers in America who've been around 20 plus years. I love those folks. They know how to Sure. Are they sponsoring happy hours at NeurIPS? No. Are they legibly listed in Build? No. Are they hanging out in my, in, situational awareness parties? No. But they're adults. I trust them.Swyx [00:05:44]: They can run LAN. They can run power.Anjney [00:05:45]: They can run LAN, power, and shell. They have credit histories. We sit down, we have a conversations. Many of them live in Silicon Valley. They've, they've had to deal with the boom and bust cycles of the internet, and I love those folks. They are stable infrastructure partners and thinkers. And I think there's a lot of short-term thinking going on in the compute layer, and it's going to catch up to us. It's not going to be good.AMP Grid: Making FLOPs Flow Like MegawattsSwyx [00:06:07]: You talk about aligning incentives, and, I would think that aligning incentives means you have the full stack in one company, which is xAI and OpenAI, right? So you as a standalone infrastructure layer, why are you somehow more aligned to your portfolio companies than people who just own the whole thing?Anjney [00:06:28]: In systems design, right, there's, there's two regimes of, architecture, right? You have integration, and then you have pooling and utilization, right? So the Or rather, the way to increase utilization often is you can do systems integration where you collapse a lot of process into one node, or you can pull out a process from a node and share that amongst various That resource amongst several different nodes. And so we see the AMP grid, which is, the, what, the system we're building here, which is basically a compute grid. We're trying to do for compute what the electric grid-Swyx [00:07:02]: PowerAnjney [00:07:02]: Yeah, what the power grid did for electricity. It-- this is a pooling and utilization layer across clouds, And so we're actually the opposite of a full stack integration like approach.Swyx [00:07:12]: Super horizontal.Anjney [00:07:13]: Where it's much more horizontal and it's, it's multi-cloud, it's multi-silicon. The goal is to try to make FLOPs flow like megawatts, and that is very hard to do today for many reasons. There's stranded pools of compute all over the place and there's no fungibility. And so right now we do it at the level of scheduling, and we often do it at the economic layer. But as we start to announce what we're working on, it's extraordinary like how many folks are coming out of the woodworks and saying, “Hey, I'm actually working on a way to make compute fungible at this part of the stack and that part of the stack.” And as a grid, we'd like all of these folks to participate on the grid. There's, people often ask me, “Andra, are you a new cloud?” And I go, “No, actually neoclouds are suppliers.” sometimes they'll ask, “Are you a venture capital firm?” I go, “No, actually they are, they are demand like sort of off-takers of the grid.” We see ourselves as what's called an independent system operator. So if you study the history of the electric grid, once it became legible to a lot of factories and industrial sort of participants that, hey, actually it turns out pooling is a good idea. We should pool our generators instead of all having a generator running at half capacity in our backyard. There was a need for an independent entity who could coordinate all these parties. Transmission line, power generation, facilities, transmission lines, factories, and that neutral coordination mechanism is very critical. In order-- If you study like the history of grids, the most enduring ones were those that never owned their own assets. They were ones that had, or often started with long-term anchors who are uncorrelated sources of demand, a steel factory, a shoe mill or whatever in a particular town who weren't competitive, where the steel factory want to spike up at night, the shoe mill wanted to spike up during the day. So then you pool and you share, right? So each of you is guaranteed some base load, but then you kind of schedule your spikes to drive a peak utilization across the town. The gold standard, so to speak, historically, has been these utility companies like PJM Interconnect in the northeast of America, where they, over many years became this what's called an ISO, an independent system operator of the grid. So that's how we see ourselves. Economically, that's what we are. From a technical perspective, we started at the scheduling layer because Seb and Mihai, who, run engineering here, built that at-Swyx [00:09:28]: Did your schedulingAnjney [00:09:28]: They did that at Google. And, -Swyx [00:09:32]: And you have infra shops from Discord as well.Anjney [00:09:35]: I have some.Swyx [00:09:35]: I don't know, I don't know if Discord is like the primary identity, but what-whatever, I'm just kind of-Anjney [00:09:39]: No, D-Discord was-Swyx [00:09:40]: Choosing a well-known name.Anjney [00:09:42]: Well, I So I was running the developer platform there. The internal infrastructure I was not responsible for. That was actually a guy by the name of Mark Smith, who was extraordinary. And yes, Discord did pool So Discord is actually a counter example. I had the chance to learn a lot about fully, full stack infra there because-Swyx [00:09:56]: It's the same thing, yeahAnjney [00:09:57]: It's the, it's the other architecture which is, Discord built its own WebRTC vo-voice and video infra. So like Discord did not use-Swyx [00:10:08]: For the calls, yeah.Anjney [00:10:09]: Yeah, did not For communication, Discord did not use third party infra. It was all built in-house. And then the way you maximize utilization was you pool demand from the world's 200 million plus monthly active gamers, right? And so that's, that's how those stacks were constructed. Again, in systems design, the two concepts that keep coming up over and over again are abstraction and composition, right? And-Swyx [00:10:31]: Bundling and unbundlingAnjney [00:10:33]: Bundling and unbundling, abstraction, composition, like verticalization and-Swyx [00:10:36]: HorizontalAnjney [00:10:36]: Horizontalization. So in that sense, AMP is an independent system operator of the grid. We pool demand, we pool supply from a number of partners we trust At about 1.3 gigawatt scale over four years. And then we pool demand from some of the world's best, research labs and so on. We're sitting at one, periodic labs who need extraordinary long-term demand. And the idea is that, each of them is guaranteed base load on the grid, but they can spike up and down flexibly on, for compute, with much shorter timelines as needed. That was roughly the design of the program I came up with at a16z called Oxygen. The same-- That was the same design of the GQM, BorgX, Borg GQM implementation at Google that Mihai and Seb had built. Which was that how do you allow, teams inside of Google, on the internal infrastructure to be guaranteed capacity, for their base workloads? But when they need to spike up on research, how could they ensure that was sufficiently there? And of course, the big innovation that was not discovered, but kind of implemented in the space, this infra space maybe three, four years ago at Google was the idea of interruptible demand, right? Where you just queue up a bunch of jobs and through this like sort of credit system, there can be a bidding mechanism.Swyx [00:11:53]: Like priorities.Anjney [00:11:54]: It's a dynamic prioritization Basically. And jobs can get interrupted based on somebody else who's saying, “what? I have 10 tokens, 10 credits I want to spend on this job.” Another like team lead, research lead is “Genie 3 or whatever is only worth five, credits, and NanoBanana2 is worth 10 credits,” and so the NanoBanana job gets priority. That's a, that's a made up example.Swyx [00:12:15]: It's very real. Brain Marketplace was real. And, we've, we've covered this on the pod with David Luan, who was-Anjney [00:12:20]: Oh, great. OkaySwyx [00:12:20]: Was there. And the criticism is that, well, actually sometimes you need central command to go all in on a thing. And actually sometimes capitalism via credits doesn't work. Not, this is not a criticism of AMP. I'm just saying, this is a thing that has been tried, internally within Google, and it led to Google missing GPT.Foundry, Frontier Labs, and Research HoardingAnjney [00:12:41]: Like, we structured ourself essentially very similarly to Google. We are structured as a holdings company. So, Alphabet holdings is Alphabet holdings, and then they've got these subsidiaries called Google and-Swyx [00:12:51]: Other betsAnjney [00:12:52]: Other bets and so on. We've got, AMP holdings, and we've got our infrastructure business, and then we've got a capital business called Foundry that incubates new frontier AI labs or invests in them as venture capital, like Periodic. We put a few hundred million dollars into Anthropic from our fund earlier this year. So wherever we feel like teams are making progress, especially researchers and so on who've pushed the frontier inside of existing labs like DeepMind, I find, there comes a point where they feel misaligned with the dictatorship of Alphabet holdings. And at that point, sometimes the dictatorship doesn't want them anymore. And they're “Thank you. You've done your job here. You've kind of helped us through the zero to one phase, and for whatever reason, we're going to deprioritize your amazing, omni model or whatever it is, and instead we're going to prioritize coding.” And, I think that's a tragedy, but I get it. They're Sergey and team are running their own business there. But that doesn't mean we the rest of us should sit around waiting for that progress to get unlocked for the rest of the world and humanity. If you think about how much extraordinary research has happened inside of DeepMind over the last 10 years, I, Demis and Sergey and those guys did such a great job. But at the end of the day, so much of that has never seen the light of day?Swyx [00:14:00]: Or they're like papers only, but they never actually shipped it to production or-Anjney [00:14:03]: What's worse is the paper is actually not even being published anymore ‘cause there's a six-month embargo inside of DeepMind, right? We've heard about this where a paper comes out, and then I think there's a six-month embargo window where if anybody on the business team says, “This could be interesting” It's embargoed for life.Swyx [00:14:18]: Exactly. So the stuff that gets published is the stuff that's not good enough.Anjney [00:14:21]: There's an adverse selection problem, basically. Yeah. At this point-Swyx [00:14:25]: It's, it's a common complaint at NeurIPS, by the way, that's “Well, why would I look at the papers that are the trash of GDM?”Anjney [00:14:31]: Again, I think it's a tragedy. I get it. They're running their business, but the rest of the I think there's negative externalities of research being hoarded, and so that'there's a market failure. And somebody needs to unlock that research, and we can't do it on our own. We only have 1.2 gigawatts of compute. That's nothing. That's about $40 billion of cloud spend. We're going to need a lot-Gigawatt-Scale Compute and End-of-Life PredictionSwyx [00:14:51]: By the way, is that's a new number. I haven't, haven't come across that gigawatt number. That's huge.Anjney [00:14:56]: Yeah. And to be clear, we haven't secured all of it. That's how much demand we have started to secure. I think publicly we haven't actually confirmed how much we have for this year. In order-Swyx [00:15:04]: Where do you want to get to?Anjney [00:15:06]: I think the steady state would be that we have a base load pool Of 1.2 gigawatts at all times Of base load capacity. For spike capacity, right now my estimate is we need roughly six gigawatts over the next four years for all our teams to feel like they were able to keep moving the frontier, whatever they're working on, whether it's, like superconductor discovery over here. There's a new investment we're working on right now, which is in the end of life prediction space in healthcare. It's extraordinary how much you can, you can give this was actually my graduate school work. I went to grad school for bioinformatics at Stanford Med. And I know we-Swyx [00:15:40]: Econ, MCS, bio.Anjney [00:15:41]: So my-- I was this really weird cat where, I was never satisfied with my major options. So at one point I was an econ major, then I was a CS major, then I was a MCS major called mathematical computational science, and they decided they were going to end that major. So I took all that coursework, and I applied it to grad school, my graduate degree in bioinformatics, which was the master's program, and then I thought I was going to do a PhD. I never ended up doing it. I dropped out and went to work at Kleiner. But I was lucky enough to apprentice with this professor at, Stanford Med. His name is Nigam Shah, and he was working on end of life prediction. Stanford is one of the only research facilities in America that has a longitudinal patient data set that's larger at scale. I think it's at least 12 million patient lives. The only larger data set is at the VA, the Veterans Affairs, of America. And to do research, like do any deep learning and so on that data set, it was called the STRIDE data set at that time, you had to be a Stanford Med School affiliate, which is why I went and enrolled in the bioinformatics department. End of deep learning was early. Nigam Shah had the visibility-- the vision to see that, you could do end of life prediction to help palliative care. In America, the, over 30% of all Medicare, Medicaid spend, at least at that time, was spent on end of life care. And what's we grew up in Asia, so we all-- Yeah, at least I won't speak for you, but I have A very different relationship with death than I find folks who grew up in America do. In America, spiritually and culturally, especially in Western societies where Christianity, the Christian tradition sort of frames death as this terminal point, there's often a judgment day and so on. The way we view death is with a finality. In Indian culture, in Hindu culture, death is one-Swyx [00:17:35]: Also, he's Buddhist as well.Anjney [00:17:36]: You're Buddhist, yeah. So it's one, it's one step in a journey of many lives, right? And so, I grew up in this city called Chennai in the south of India, and when people die, you dance on the street. There's like a procession where your body is carried to be cremated and your family, like celebrates and there's drums and so on. It's this huge thing. And, It's because the idea is that you're going to be reincarnated. You've been liberated from the responsibilities of this life, and now you're onto your next. It's a new It's like going off to a new college or whatever, right? And so it was so alien to me when I got here as an undergrad- That the medical system works backwards from that assumption that we have to view death as this terminal thing and delay it, postpone it's a bad thing. And so at the time, clinical decision support in the United States was this very primitive field. Even to this day, physicians in the United States often will tell you when you have a terminal disease, this is your, we've diagnosed you, which is great. Our ability to diagnose you is extraordinary. You have somewhere between six months to six years to live. What do you do with that information? The error bars are so high that then you In times of uncertainty, we default to culture, and when the culture is let's-- this is a bad thing, I've got to prolong my life, then you start doing things like And just to, just sort of from a systems perspective, what's going on there is Physicians often feel like they need to provide such high error bars because there's always some uncertainty in end of life diagnosis, and if you provide the wrong Diagnosis or recommendation to your patient, you can be sued for medical malpractice. And then your license can be taken away. It can be catastrophic for your career. In contrast, if in countries where that's not the case, what you often observe is that patients, physicians are quite prescriptive with their recommendation. They say, “Hey, this is your condition. The literature says that you probably have this much time on Earth left. My expert opinion is that you are an outlier or whatever.” And they try to be more prescriptive, and that empowers a patient, right? ‘Cause then a patient can say, “I trust my doctor. They said on average, I have six months to live, but if I do these things, I may have a shot because of my particular predispositions or my genetic history or whatever.” And that empowers you to go about your life in a actually more scientific way than leaning on religion, culture, spirituality, and so on. In contrast, here, because of that medical malpractice sort of thing looming over your head, a physician never gives you a clear recommendation. So instead you say, “Okay, Doc, well, let's try it all.” And then you start a whole regime of drugs and therapies, and then you often spend weeks and weeks in the hospital, and that deteriorates your quality of life. And when that deteriorates your quality of life, you instead of spending your last few days doing the things you love with your family, you're spending it on a hospital bed. And that ends up being thirty percent of Medicare and Medicaid. So it's worse for the patients. The doctors feel terrible. The American taxpayer is paying a huge amount of money. And so this is why Nigam Shah, who was this professor at Stanford, said, “Anjney, if there's “ I kind of sat down with him. I was this young, I'd, I was twenty-one, and I was “I want to work on a big problem.” He's “The big problem is end of life care.” And so we tried to do deep learning to say, to-- So we started trying to run deep learning on these tried patient data sets to say, “Could you have an AI system make a recommendation that is orders of magnitude more precise about how much time you have left once you've been diagnosed with a terminal condition than a human?” And then if we can get that precision to be high enough, then you can empower the patient. And it turns out the tech works. Like it's-- Once you get the data set, like RL works. Honestly, even regression models work. You don't need to get that fancy. At the time, we were just trying, doing like very simple neural nets.Swyx [00:21:54]: Simple solutions, yeah.Anjney [00:21:54]: Today, what we can do with RL is extraordinary. The problem remains then and now is regulatory, because you actually can't shift the burden of the wrong clinical diagnoses from the physician to the AI system. And so at that time, I got quite disillusioned ten years ago for, twelve years ago where, ‘cause I felt I just didn't have the resources to influence regulation. Today, I'm very lucky. I'm in a different place. I've, I'm a lot older, and so I've been spending a lot of time on my next incubation, which is how can we unlock the, patient empowerment by training AI models to do end of life prediction much, with much more precision and ac-Swyx [00:22:37]: Oh, wow. You're still focused on this the whole time.Anjney [00:22:40]: The-- I haven't been able to get, this out of my mind a single day for the last fourteen years. This is the hill I want, I would like to die on. There's two, I would say. What? I actually, I'd prefer not to die.Swyx [00:22:51]: Yeah, exactly.Anjney [00:22:52]: But I think two bipartisan issues, I think two issues that should be bipartisan in America are how do we empower patients to make the right clinical decisions at the end of their life, such that we're reducing the taxpayer burden with science? It's just good old science, and AI can help here. And the second is, net positive data centers, ‘cause I think that's the biggest critical bottleneck on training and good enough AI models to help people at the end of their life. So there's sort of two sides of the, of the same scaling bottleneck curve, but those two, we formed AMP as a public benefit corporation. My wife and I, who you've met, you've met Viv. Her passion is education. Her family is a long line of educators and so on, and, of physicists. And so this class is my attempt to stop being the black sheep of the family and be a, an educator. But if I'm not educating, the thing I would be doing is working, on these two problems, whether on the political spectrum or as a researcher back at, in some lab. And my hope is if anyone's listening to this podcast, if they're passionate about either of those two topics, I'd love to hear from them. We'll, we'll we can share the contact in the show notes, but, we're looking for people to join both of those missions on the, on the political side as well as on the medical side, on the research side.Frontier Systems, Output Maxing, and AlignmentSwyx [00:24:08]: You said, this is a discipline that you want to form. You call it's called variously called Frontier System. It's variously called One Person Frontier Lab. What is the ideal name or shape of this? Like the, what is the mission?Anjney [00:24:24]: Of the class?Swyx [00:24:26]: Of the discipline that you're, exploring, right? I The class is called Frontier Systems. But like for me, maybe one phrase is you're, you're just anti-waste, right? Which is wasting GPUs, wasting in human and Medicare. But is there, is there a broader theme that I'm, that maybe you can encapsulate more succinctly?Anjney [00:24:45]: Yeah. The, from an engineering perspective, it's very simple. It's output maxing. It's the, it's the department of output maxing.Swyx [00:24:51]: Making the most of what we have.Anjney [00:24:52]: Exactly. I'm a huge believer in optimal outcomes. I think both in America and other countries, we are losing our appreciation for nuance, and this is the thing of And AI is the same case, right? Oh, the bitter lesson holds. Okay, fine. But that doesn't mean you just like throw 500 GB300, 500,000 GB300s at your suboptimal model scaling and you waste a bunch of compute. It also doesn't mean that, the most optimal is to have like 50 different architectures where there isn't enough standardization. One of the reasons Anthropic has had extraordinary sort of velocity is ‘cause they picked the transform architecture and said, “This is simple. Let's double down on it,” right? And now luckily there's enough investment going to the space that we can afford other architectures, but at the time, investment was just too fragmented into other architectures, so that arguably unlocked scaling. So I think there's a philosophy. I think we all owe it to ourselves to do output maxing with a new capability called AI on a global level. I think if I was starting a new department at Stanford, depending on how fuzzy or technical I wanted to be, I'd probably call it the Department of Alignment. Like-Swyx [00:25:59]: It's an overloaded termAnjney [00:26:01]: But it is, But alignment really Is a hard problem. And I think when you unlock it, full stack alignment is super hard in any organization and in any system. Like in a, in a venture capital firm, if you can have full stack alignment between your limited partners and your, the founders who are creating the value and ultimately the public that owns the IPO stock, that is a gift that keeps giving. And when you study the history of these systems, when they start off, they usually start out small scale where the feedback loop is actually so tight that there's alignment. And then the more you try to scale, the more division of labor happens, the more specialization happens, and at each step you add abstractions. And wherever there's an API interface, there's like loss. There's communication loss. And so I think a really cool thing would be for us to figure out is there a way for us to have our cake and eat it too as an engineering discipline? Is there a way to actually scale up and scale out Without losing any alignment, without lossy transmission?Swyx [00:27:01]: You mean standards?Anjney [00:27:02]: So standards is one way. The other way is you just have net new capabilities. So like what we're trying to do here is discover new superconductors. A room temperature superconductor would be a lossless transmission mechanism for energy. We would have flying cars. We are right within a few years of having a new room temperature superconductor. So I think those are the two. You either have to standardize On protocols or API specs that allow lossless communication, or you can come up with a whole new capability that unlocks so much abundance, the standardization doesn't matter ‘cause you just unlock net new capacity. This, the, so this is what I spend my days thinking about these days.Compute Markets, SF Compute, and Non-NVIDIA ChipsSwyx [00:27:38]: No, I think every infra person at, who wants scale and wants to output max does eventually end up thinking about this. We don't have time to go into it, but we have done an episode with SF Compute-Anjney [00:27:50]: Oh, coolSwyx [00:27:50]: That is trying to standardize The futures contract for compute. I don't, I don't know how that's going by the way, but like at some point this will be public.Anjney [00:27:57]: Oh, I think Evan is awesome and SF Compute is the kind of effort that I hope we can accelerate because what often happens is these exchanges are very hard to get, they, it's hard to bootstrap them, right? Because they often require-- There's many inefficiencies between parties. There's trust boundary inefficiencies in infrastructure because you don't trust, one part of the stack doesn't trust another part of the stack to give them visibility. There's capital markets inefficiencies, there's operational efficiencies. So if you can inject like a single shock to the system of a ton of compute demand or supply, then you can accelerate, these new flywheels. And so my hope is one day, or soon, if SF Compute needs extra like has excess capacity, they just hook it up to the grid and they get flooded with demand from us. And on the other side, if they have a ton of demand but they don't have supply, they just again hook up to the grid and it's a two-way protocol where they can just hook up to our capacity. And I don't think we're too far from that. Today our working implementation of it is mostly through a group of labs, universities, and a few sort of trusted parties who are, who all feel like they're in alignment to borrow an over sort of used word. But our hope is to just have it be an open protocol that anyone can hook up to on-Swyx [00:29:20]: Hook up for demand or hook up for supply? In primarily demand, it sounds like. Like you-Anjney [00:29:25]: No, bothSwyx [00:29:26]: You would want to offer demand.Anjney [00:29:27]: Both. Yeah. Unfortunately, what's happened in the last six weeks is, we thought we'd have a bunch of excess capacity by the end of this year. It's all gone.Swyx [00:29:37]: It's exploding.Anjney [00:29:38]: It, yeah. It's all gone. And so I have, my text messages are full of friends, we know many of these people, these are founders who've raised billions of dollars in San Francisco going, “Oh, any chance you have like 50 nodes in the next few weeks?”Swyx [00:29:51]: What is the scope for, non-Nvidia, right? You have Lisa Su coming and, Rainer Pope as well. And so There is a lot of demand for, more performance Alternative architectures and all that. At the same time, this hurts your standardization.Anjney [00:30:11]: I don't think so. So actually Rainer's a great example, right? Rainer is a CEO and founder of, MatX. I actually had him by for office hours in the class earlier today, and there was an insight he brought up that I hadn't considered before, which is when they decided to pick the standard For their data center, they picked the NVIDIA reference architecture. So the MatX chips Just plug in to any site that has an NVIDIA bring up planned. And, the-Swyx [00:30:42]: It's just software then. It's, it's not the-Anjney [00:30:44]: A-Swyx [00:30:44]: Hardware.Anjney [00:30:46]: Well, from an input and IO perspective It's the same footprint as an NVIDIA rack.Swyx [00:30:52]: That makes sense.Anjney [00:30:53]: Where they have done, innovated a bunch from what I can tell is on systems co-design. Which is where a lot of the gains are to be had. And so he picked He was “Anjney, we, there's just so much work to do when you're building a new chip company.”Swyx [00:31:08]: Can't fight every front.Anjney [00:31:08]: You just can't fight on every front. So my question to him was, “Well, you're working on this new chip. Their tape-out is next year. What, who are you going to partner with to host the chips?” And he said, “Whoever will host them. That's just not, that's not my focus.” And I said, “But how did you “ you decided back to our earlier systems design question, he decided that, he didn't want to be a full, fully integrated chip provider. The bottleneck they're focused on is the logic die, and they, he feels they can crank out a ton of performance gains through co-design there. But then that means you delegate, to our question earlier, it, you he's the data center provider is a different part of the stack, and so then he's dependent on that part of the ecosystem to host his chips to get the performance gains to the customer. So now you have another abstraction, and you might have loss. So I asked him, “How do you prevent loss?” And back to your point, he said, “I just picked the NVIDIA standard ‘cause I didn't want to Like I wanted to piggyback off of an existing protocol.” And that, what's great about NVIDIA is that reference architecture is known.Swyx [00:32:15]: Open.Anjney [00:32:15]: It's open. They've published it. So Jensen's actually enabled someone like Rainer to build a chip company like MatX, and I don't see them as competitive. The compute demand is so high. Like, I don't I think NVIDIA's not able to meet the demands of production, so we just need more chips. And I think it's very smart what MatX has done, which is say, “We're just going to we're not going to innovate on the data center design ‘cause actually, thank you, Jensen, you've done all the hard work. Where we can innovate is somewhere else.” And I think that's, that's very healthy. I think that's how we unblock new bottlenecks. And my view is these, the, chip teams like MatX, who have arrived at the insight that co-design is the way, The primary bottleneck for them is trust boundary. To do co-design well, you need visibility into the next model generation as soon as possible ‘cause it takes two years to tape out. So if by the time I bring my chip to market, your model architecture's changed, I'm host. Now, when he was inside Google, he was sitting next to the Gemini team. He was on Palm or whatever.Trust Boundaries, Co-Design, and Researcher CEOsSwyx [00:33:19]: His co-founder was the, was one, was one of the Palm guys, I think.Anjney [00:33:23]: Yes. Yes, exactly. So when you're inside the trust boundary of Google, then your systems co-design loop is super tight. When you leave as a founder, one of the biggest risks you take is now you're outside the trust boundary. And so what I love doing is helping chip teams who can help us unlock more capacity for the independent ecosystem access to trust. Because when I If I've been, involved with a lab from day one, and I was lucky enough to work with Anthropic, and then I'm on the board of Mistral and helped Black Forest Labs get started. I think at this point I'm on six or seven different teams.Swyx [00:33:57]: Only six? I feel like my mental number was going to be 13, but yeah, it's-Anjney [00:34:02]: No, I go deep with one at a time.Swyx [00:34:04]: You're founding CEO of Arena.Anjney [00:34:07]: Nah, that was an, that was an-Swyx [00:34:08]: Administrative CEOAnjney [00:34:09]: It was an administrative five-month gig where Whalen and Anastasios were graduating from their PhDs, and they didn't need a product team. So I helped recruit the head of engineering product and design. But Anastasios has always been the CEO of that company. I played a pinch-hitting I'm an intern. I was CEO intern For five months. -Swyx [00:34:33]: I interviewed him, and he's he's very well-spoken. I think he's a debate, former debate, champion. But also very quantitative and mathematical, which is-Anjney [00:34:41]: He-Swyx [00:34:41]: Such a unicorn.Anjney [00:34:43]: See, what's amazing about him? If you look at his output, he's an output maxer. By the time he was graduating from his PhD, which he only graduated last year, he had published more work with a citation count than, people twice his age. But at the same time, he'd already started a project called LLM Arena that was being used by millions of people As a side project. And time and time again, what I've realized is venture capitalists suck at seeing human beings as, dynamic agents where-Swyx [00:35:14]: They want to put you in a boxAnjney [00:35:15]: They want to put you in a box.Swyx [00:35:15]: This is your thing.Anjney [00:35:16]: So the first time I got introduced to Anastasios, somebody had told me “Oh, he's amazing, but he's a researcher.” I was “what? What do you mean he's a researcher?” That's what-Swyx [00:35:28]: Like he's not a CEO, not a founder.Anjney [00:35:29]: Not a CEO, exactly. I was “Are you crazy? Do you Have you met Dario?” Dario's a scientist. He's gone from zero to, what will soon be a trillion-dollar company in four years. Being a CEO, nominally speaking, is not that hard. Being a good CEO is hard. Being a great CEO actually requires a level of performance that scientists who have already published at the top of their field have accomplished. It is super hard to be a competitive scientist. To publish in academia over the last 20, 30 years, to make it to the top of your discipline at a place like Berkeley, you are a star athlete. Like, you are an athlete of the mind, and you perform at the highest levels. And to get there, whether you're, Anastasios or Whalen at Berkeley, or you are Robin, who-Swyx [00:36:23]: BFL, yeahAnjney [00:36:24]: With Black Forest, who created Stable Diffusion, or if you're, like Guillaume at Meta, who created Llama before he started Mistral. The amount of human leadership you have to demonstrate to get the resources, like get the trust of the organization, publish it, put it up. I would just fund researchers all day Right? If who have contributed already to the field. If they've, if they've put SOTA out there, they're, they're star athletes already. If they haven't done SOTA Look, they can still be good CEOs, but then I find the failure mode is that they just don't want to be CEOs, they primarily want to publish, and that's okay, too. One of the things we do with the AMP Grid is we donate excess compute. We have two nonprofits, like university labs. We carved out like a couple thousand H100s. But I do think there's extraordinary research being done on university campuses. My father-in-law's a physicist. He's a professor. Extraordinary work in physics, and we need that. But if you want to be a CEO, what you need to be willing To do is be super confrontational, outside of science. Like within the scientific community, some of the best researchers are very confrontational about their convictions, right? This architecture is right. To be a great CEO, you basically have to be willing to be confrontational up and down the stack.Swyx [00:37:41]: To your own team.Anjney [00:37:42]: To your own team-Swyx [00:37:43]: To customersAnjney [00:37:43]: Hiring, recruiting customers. Well, I would say, Yeah, pretty much to everyone Everybody. Of course-Swyx [00:37:50]: I see, I feel a little bit of that in my own work, but yeah, I can't imagine the stakes that Dario has had to go through. It's, it's pretty insane.Anjney [00:37:56]: No, I don't think the stakes are that different From how you're feeling it, right? Stakes are personal scaling vectors, right? The stakes that seem so low to you, like having this podcast where you can talk to somebody and just have a you're an extraordinary communicator, right? Like already in this conversation, you've pulled more out of me than most people, and I've been on 12 podcasts in the last two weeks.AI Coachella and First-Principles ThinkingSwyx [00:38:17]: I think I, we've just seen each other enough that there's some base trust.Anjney [00:38:20]: There's base trust.Swyx [00:38:20]: And I think, and I know that you, that I've done my homework and like I know that trust is a big deal for you, so.Anjney [00:38:27]: I think trust is about consistency, and you and I have seen each other In the community for years, right? Like, I remember the first time we met was at NeurIPS in New Orleans. I don't know if you remember that, luncheon.Swyx [00:38:38]: Oh my God.Anjney [00:38:39]: Reiko had set up this Reiko's amazing, and he set up this luncheon and-Swyx [00:38:43]: Yeah, I was “Who's this Discord guy?” I'm “Okay.” But-Anjney [00:38:45]: No, you weren't-Swyx [00:38:46]: You were just “You made some investments.”Anjney [00:38:47]: You were much less polite. You were “Who's this VC?” You're like-Swyx [00:38:51]: No, I Was I? Oh my God.Anjney [00:38:53]: It was-Swyx [00:38:53]: I'm so sorryAnjney [00:38:53]: It was visible on your face.Swyx [00:38:54]: I'm so sorry. But you weren't, you weren't The introduction was bad. I was I didn't know who you were.Anjney [00:39:00]: The, see, this is the thing about context, right? Like, but then I think I heard your accent. And I was “Are you-”Swyx [00:39:06]: Singapore, yeahAnjney [00:39:06]: “Are you Singaporean?” And you're “Yeah.” And I said, “I went to high school, JC, in Singapore.” And then the ice broke. But This is the there are in the scientific community, sometimes the stakes are very high for people who haven't had the emotional, what is called EQ Coaching and mentorship, right? Which is like to have scientific impact, you often need to be a extraordinary emotional, like emotionally in tune person with the folks you're trying to influence. And so what comes so naturally to you is actually a super high stakes thing to other people. And so I wouldn't assume that Dario's more stressed out than you. These things are you'd be surprised how similar and small sometimes the problems are to you That some of the world's biggest, leaders are facing. And that's what I've learned from this class. The guest speakers are Sam, Satya, Jensen.Swyx [00:40:01]: AI Coachella.Anjney [00:40:02]: Yeah. It's AI Coachella, right? So we got to get all the headliners, and they're I'm very lucky that some of these people have either mentored me over the years or I've done business with them. And when you, take the performative stuff out and any assumptions you may have about these people that you read in the press or on Twitter, We're all just humans. We're all trying to get along. And what's so special about this moment is AI is forcing, like scaling, the bitter lesson is forcing a lot of people to revise their assumptions for how the world works and go back to first principles or go and educate themselves. So the kind of people I was, I won't name who this person is, but I was at an event last week in Texas and, ran to somebody who said, “Anjney, I came across the class. What do you think about real time action prediction models?” And I was, don't know how happy it made me feel when they asked me that question. I know they've done the work. They've challenged themselves. I'm, they didn't ask me, “What do you think of world models?” They said, “What do you think of n-”Swyx [00:41:04]: Real time action predictionAnjney [00:41:05]: “action, real time action prediction models?” World models, don't get me wrong, are cool and everything, but you and I both know that is a layer of abstraction that is sometimes not usefully precise enough. Right? Ours-Swyx [00:41:16]: There's like four different kinds of world models.Anjney [00:41:17]: Yes, exactly.Swyx [00:41:18]: We've done the part with general intuition, by the way, which is very focused on, -Anjney [00:41:22]: Oh, cool. Yes. I love Pim. Pim is great. And this is what I love about people who've done that level of work. They realize they're not in competition with people who the rest of the world thinks they're in competition with.Swyx [00:41:34]: Because they're not in the category, they're in the specific thing they're trying to do.Anjney [00:41:37]: They're focused on their mission, and they have a systems understanding of the bottleneck they're trying to solve. And when somebody else says, “I'm working on real time, action prediction models too,” Pim goes, “Oh, I love that person. I want, I can learn from them.” But the minute they're “Oh, that person's a world model person,” it's “like which type of world model person?” But mostly they're just trying to figure out if it's a waste of their time, because we don't have enough time. So, Pim, for example, is super, loves this other company I work with we've talked about called Black Forest Labs. And he's mentioned to me multiple times that he's so, He thinks what Flux is doing is really cool. Andy Blattman came by and spoke in the class. And what I find over and over again is for people who do the work, who can be usefully precise enough about like what is actually going on in the world of frontier research, The sense of camaraderie is still well and alive, but it gets lost sometimes when you have to like abstract The technical complexities in, business terms And then the VCs are “How are you different from that world model?” I'm going to say Where do I even start to explain this stuff? And then the misalignment creeps in.Leading vs. Winning in Frontier AISwyx [00:42:43]: This is good. Yeah, I think, people listening get a sense of, what it is like to operate at a real level, like yourself, rather than at, the journalist level, where you have to sort of put everyone in, a rough category and create a narrative of competition, and who's winning today, who's behind.Anjney [00:42:58]: It-- this idea of winning is so Weird to me.Swyx [00:43:03]: You do want to win. You want you want competitiveness.Anjney [00:43:06]: No, I think you want to lead.Swyx [00:43:07]: You want SOTA.Anjney [00:43:07]: No, I think you want to lead. Yes, so you want to push the frontier. You want to push the SOTA. You want to do something that hasn't been done before. You want to capture value, but you don't want to capture so much value that, people think you're unaligned with your mission or trying to do what's best for the world. You want to capture enough value that you can keep innovating, right? And I think that people want to lead, they don't really This idea of winning and losing, again, I love Jensen. He's a, he's a leader. The mindset that he talked about on Dwarkesh's podcast, right? He's “I didn't wake up with a loser mindset.” I think that was awesome, right? Because he's, he's an engineer. Dwarkesh has done the work. So there's at least-- even though the, to me, it was very obvious they're talking about the same thing, they just passed each other. They just had to basically, Jensen has this, five-layer cake abstraction of how the industry works. And Dwarkesh had, I think from that podcast, had more of, a pre-training, mid-training, post-training systems loop concept.Swyx [00:44:04]: It's just a factor of who he talks to, right? Again, it's very clear.Anjney [00:44:06]: It's the systems It's the abstraction, the mental models, the It's the whole-- Dude, so much of the problem in the world is reasoning by analogy. And then the assumptions that are held invisibly.Swyx [00:44:19]: Yeah, I've, I've said, this is actually the best time in human history for first principles thinkers. Because everything you think will happen is actually now coming true.Anjney [00:44:28]: Correct. And the venture capital community is, notorious for this, where people look-- In times of uncertainty, they, cling to axioms that ended up being true from the previous era, and they kind of like proclaim them with confidence as if they're truths, but they're not. And it's very important to see the distinction between a heuristic and an axiom. An axiom can be proven-Swyx [00:44:55]: Like from internal consistency point of viewAnjney [00:44:56]: With internal consistency. A heuristic is a way you kind of a shortcut. And my God, the number of people I have had to put up with over the last few years who proclaim-- use heuristics As axioms to judge people, to judge which companies are going to succeed or the number of people who are “Oh, yeah, Anthropic, they're just training models right now,” but this one continue.Swyx [00:45:22]: Because that's a B2B SaaS?Anjney [00:45:23]: Yeah, the, like Which over the fullness of time, if you squint at it, maybe. But the way you arrive there is so important that you can-- you just, you can dismiss people. Here's what happened, right? What happened is Anthropic basically achieved takeoff in October of last year. That training run-Swyx [00:45:41]: Whatever, three seven?Anjney [00:45:42]: I forget the numbers now, but whatever that checkpoint was-Swyx [00:45:45]: We saw the cognition.Anjney [00:45:46]: Yeah. Right? You probably-- The, to those of us in the community, especially once post-training was done and it was released in December-Swyx [00:45:52]: Yeah. Can I sneak a sneaky question in there? I don't know if you have a perspective, maybe you don't, I just The number one question is how did Anthropic crack coding, right? Because Claude One, Claude Two, okay, like it was part of it, but it wasn't a big deal. And the leading hypothesis, it's a lucky dice roll that was then compounded, right? Like it was like Mildly better, but then they saw it and they were “Okay, let's really invest.”How Anthropic Cracked CodingAnjney [00:46:17]: I had this very annoying teacher. I went to this boarding school called Rishi Valley in India, which is like this, bird preserve. It's like three hundred and fifty acres of bird preserve in rural India, and there was no technology for seven years. There was this teacher, I won't name them, but they would have this-- I hated it every time he said this to me. He was “Luck fa-favors the prepared mind,” which is like a common saying, but the way he delivered it, always grated me, ‘cause he was always I was always one of those kids who got, a good grade without trying very hard. ‘Cause like high middle school is not that hard if you, if you're generally, paying attention and so on. And there was this one time where I-- But then I would get an eighty percent grade, and he would keep pushing me to say “The reason you didn't get the ninety-five plus percent is because you're not that lucky.” And I would say, “What do you mean?” ‘Cause I would think that I deserved that grade, and I would sometimes argue with him. And he'd say, “You didn't have a prepared mind. If you want to get lucky again “ There was basically one time where I got like ninety-five or ninety-six on this, on this subject, and I, now that I felt entitled. I was “Okay, I'm going to keep doing this,” and I didn't. And then he was “Luck favors a prepared mind. You got lucky last time, but you got to stay prepared.” And I didn't understand what he meant. Now, as I'm older, I'm okay, these adults actually knew a thing or two. Anthropic has been the most prepared company for four years. And so then when the right, context data comes in, the right developers start sending in, the right context diffs, Sure, you could say you got lucky, but if you ask me, they're pr-pretty damn prepared with paranoia for like four years. And you have to remember, it was so hard for them to get going early on that they had to do so much more with so much less that you just have to be prepared to be so efficient.Swyx [00:48:06]: Yes. There's numbers on their burn compared to OpenAI. I've, I've written about it, but they are so much more efficient in their, in their tech stack.Anjney [00:48:14]: It's not even It's not funny.Swyx [00:48:14]: Not even close.Anjney [00:48:15]: Yeah. But it's so clear, right? Like how to output max for the world. They have been prepared, and you could call that luck, but Luck favors the prepared mind.Culture, Hardship, and Anthropic's P0Swyx [00:48:25]: This is one of those things that I was going over some of your old lectures and, you were data, people think it's a moat and actually it's culture and actually it's team Actually. And I, it's-- there's different levels of moats, and this is the ultimate one that determines everything else. Which you can then compoundAnjney [00:48:43]: You're saying culture is the ultimate moat? Yeah. But the thing about culture is it's very fragile. So moats, I don't think they're-- there's very few moats I found that are actually moats. They're-- It's, it's a nice concept, but in reality, you have to replenish your culture. Ben Horowitz was, the speaker in CS153 on Tuesday, and I asked him this question about the culture bottleneck in teams because, there are several AI teams-Swyx [00:49:09]: His book, Hard Things About Hard ThingsAnjney [00:49:11]: Hard Thing About Hard Things. But more concretely, there are so many AI labs today that have all the cash they need, they have all the compute they need, and they're still not able to ship anything SOTA. And then you start seeing people leave and so on, and my diagnosis, it's, is it's the culture. And so I asked him, Ben, they're-- He's been one of the most aggressive investors in AI labs. He goes back to this thing which resonates in my mind a lot. It-- When I used to work at a16z, I would, book a conference room, and right outside the conference room, which is closest to the toilet ‘cause it was the fastest way for me to go use the bathroom between Zoom meetings-Swyx [00:49:45]: Oh my God, I'll put maxing my toilet optimization. Okay, never mind.Anjney [00:49:48]: It was not healthy in hindsight, but maybe this is TMI. But anyway, outside that conference on the wall was this quote that was printed that said, “Culture is not a set of beliefs, it's a set of actions.” And it's by Bushido, is this, Japanese philosopher. And if you stop taking the actions that demonstrate the mission alignment to what you've said to your team and to your-- the world matters to you, then your culture starts to fray. So it's not actually a moat, I would say. It's a very brittle, fragile thing that requires daily tending to like a garden. But if you figure out the system to keep that garden tended, which I think ultimately comes down to knowing yourself ‘cause you most naturally, if you're authentic and so on, you'll naturally make trade-offs that seem effortless to you, but that reinforce your culture. And then That becomes this very hard thing for other people to catch up to. And at Anthropic, from day one, there was this mission like-- missionary like zeal and belief that, hey, these capabilities will scale. These systems are stochastic, not deterministic. There will be error bars, and until we crack interpretability, there's risk. And at some point, people will go-- stop using Claude just for coding. They'll use it in some mission-critical context where there's-- it'll throw off a bug, and then people are going to come blame them, and they want to be on the right side of history where they said, “Yes, this is a powerful technology. We think it's going to change the world, And we want to be very measured and scientific about the fact that, ‘Hey, guys, these are stats models, statistical models.' That's how statistics works.” ultimately, when you're training neural nets, it is just a statistical system. And I think that Belief that safety is important and that it might seem toy-like in the early days, and sometimes, you could say, “Anjney, they totally over-exaggerated the risk,” like two years ago when they said, “Let's not launch Claude One,” or whatever. Well, okay, maybe in hindsight, but hindsight is twenty/twenty. And at the time, they didn't know how that model would be used, and to them it felt existential if somebody came and said, “You weren't responsible. It-- This wrote a bug.” The liability associated with that is massive. So how do you prevent against that? Well, day in, day out, you say safety. And when you start deviating from that, you have the team hold you accountable, you have the world hold you accountable, and I think that becomes a moat over time. At some point, that moat will get challenged and so on, and then it become fragile. I hope it endures because that's the beauty of having founders run the show, ‘cause they can make really hard trade-offs to do mission alignment. The hardest part is in the earliest days when you don't have a group of people who are going through difficulty, stress, crisis together, then your culture doesn't get defined sharply enough, and that's what I'm worried about right now, is there's so much money going to these labs. There's no hardship. There's no-Swyx [00:52:50]: To anyone who knowsAnjney [00:52:51]: There's no to anyone who knows. And that, in hindsight, was a feature, not a bug for Anthropic. The number of people who said no, the number of people who said, “Sorry, we're all doing investors in OpenAI,” that is competitive difference. It forces you to really understand, what is the hill you want to die on at the expense of everything else. What's the P zero? And there, P zero from day one was coding. The reason, the mechanism system there was if we crack coding, Then we will crack AGI. Our mission is AGI. We want to get there safely. If we focus on codin

Physicians earning $400K are living paycheck to paycheck—and an 18th-century psychology trap is why.  Roughly 30% of doctors over 60 don't have $1M in net worth, even counting their home. Justin Harvey and Dr. Jimmy Turner unpack the behavioral-finance forces—the Diderot Effect, lifestyle creep, and leverage—that quietly erode physician wealth, and the simple framework that lets you spend guilt-free while still building real options.Resources: Disability Insurance: Every physician needs Disability Insurance from MMM Disability Insurance. Click here to get a Quote from Money Meets Medicine Disability Insurance Looking for a new CPA? Use the one that Dr. Jimmy Turner personally uses and recommends (Gelt). Click here to get a 10% discount code on services when working with Gelt. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week, we discuss endovascular therapy for post-thrombotic syndrome, new evidence on prehospital blood transfusion strategies in trauma patients, and a trial of cefazolin for Staph. aureus bacteremia. We examine evolving approaches to thyroid cancer and share a case of a man with pancytopenia after heart transplantation. Perspectives explore psychedelic therapy, the convergence of Down syndrome and Alzheimer's disease, and treating addiction.

Dr. Steven on California's New Laws Curbing Private Equity Control of Medical PracticesIn this episode of The Pediatric Lounge, the hosts welcome back Dr. Steven from California to discuss two new state laws addressing private equity and the corporate practice of medicine. Dr. Steven describes his key role as a witness supporting SB 351, which strengthens enforcement against MSOs and private equity interfering with clinical judgment, physician scheduling, work hours, medical record control, and certain restrictive covenants and NDAs tied to quality and ethical concerns. He shares his own experience of alleged MSO interference, including canceled COVID vaccine clinics and loss of control of his professional corporation, now part of a lawsuit. They also review AB 1415, requiring disclosure and greater oversight of healthcare transactions, and compare similar issues in dentistry and leveraged buyouts, arguing financial incentives can harm patient care and physician autonomy while weakening relationships and access in larger systems.00:00 Podcast Intro00:29 Catching Up in California01:04 Surf and Wave Safety02:20 How SB 351 Passed03:17 Enforcing Corporate Practice07:12 MSO Interference Examples11:22 Noncompetes and NDAs13:15 Deal Disclosure Law AB 141514:48 Dental PE and LBO Debt17:51 Pediatrics Margins and Debt19:44 Urgent Care and Midlevels23:00 Who Pays the Debt23:48 Wall Street Gambling Mindset25:15 Money Over Patients25:37 Recruit Then Replace26:52 Leverage And Lending28:40 Physician Exit Strategy31:17 Independence Comeback34:26 Access And Pricing Failures36:04 Referral Barriers And Triage40:17 Relationships Lost In Medicine43:05 Teaching The Next Generation44:08 Closing Thanks And CreditsSupport the show

This episode is sponsored by Bluesky CBD and Alloy. Bluesky CBD: Get to sleep faster, experience more restorative sleep and save 30% with code FLIPPING50 at https://www.bluesky-cbd.com/discount/Flipping50. Alloy - Get your menopause treatment plan today. Visit https://myalloy.com and use code FLIPPING50 for $20 off your first order! #AgeGracefully Other Episodes You Might Like: Previous Episode - 25 Simple Rules for Optimal Health, Wellness & Fitness over 50 Next Episode - Muscle and Strength Loss Prevention After 50: A Checklist More Like This - What Is Sarcopenia and How to Avoid Sarcopenia In Menopause Resources: Get YOLKED with Fortetropin, a revolutionary supplement that helps fuel muscle growth and enhance recovery. Get powered by Mitopure®! The nutrient that can re‑energize cells with a breakthrough for healthy aging. Use code FLIPPING50 to claim your 20% discount. Collagen Boost is an unflavored source of bioactive collagen peptides designed to support skin and nails as well as healthy joints, bones, ligaments, and tendons. Use code PODCOLLAGEN10 to claim your 10% discount. Try the Lofta Home Sleep Test for sleep apnea in the comfort of your own home. Use Flipping 50 Scorecard & Guide to measure what matters with an easy at-home self-assessment test you can do in minutes. Muscle loss and sarcopenia have been synonymous with aging in previous generations. Muscle loss impacts osteoporosis, balance, stability, independence, and hormone balance.  In this episode we'll talk about the 3 M's and how to bank muscle looking forward to a time off your fee as well as how to get it back if you have muscle loss and sarcopenia.  My Guest: Dr. Chris Meletis is an internationally recognized educator, author, lecturer, and functional medicine practitioner with more than 33 years of clinical experience. He has authored 18 books and over 200 scientific articles, contributing extensively to the fields of naturopathic and integrative medicine.  Formerly the Dean of Naturopathic Medicine and Chief Medical Officer at the National College of Naturopathic Medicine, he was honored as Physician of the Year by the American Association of Naturopathic Physicians. Passionate about accessible healthcare, he helped establish 16 free natural medicine clinics and continues to focus on the GI microbiome, mitochondrial health, nutritional biochemistry, and botanical medicine. Questions We Answer in This Episode: What trends have you seen in aging, and why does muscle become such a critical issue for women in midlife and beyond? Are physicians beginning to use muscle-related assessments as vital signs, and should strength be monitored more routinely as we age? What does grip strength actually measure, and why is it such a powerful indicator of overall strength and future health? What happens when you need a bunion surgery, joint replacement, or another procedure that temporarily limits activity? Will you lose muscle, and how can you prepare for it? If you're told to lose weight before a knee or hip replacement, how do you protect muscle mass while improving your health outcomes? Are we eating enough protein, and is our digestion allowing us to actually absorb and utilize it as we age? How can muscle-support strategies help during periods of bed rest, illness, pain, long COVID, or other situations that increase the risk of sarcopenia? What should active women do when they're already exercising but still struggle with maintaining muscle, energy, or lean body mass? If this episode made you flip your workout routine — share it!

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

The medical system wasn't built for women who ask too many questions, need more time, or leave an exam still wanting answers. As a result many women have learned not to trust their bodies and their needs. Nikki Vinckier, a Physician's Assistant, spent a decade working in medical care before she decided to write the manual it didn't come with.This conversation is not just about what's broken, but about what you can actually do about it before your next appointment.In this episode you'll hear:How the history of reproductive healthcare still shows up in exam rooms todayWhat medical gaslighting is and why autistic women are especially vulnerableWhy a clinician can't address your health issues during your annual exam How to communicate symptoms when the one-to-ten scale makes no sense for your brainThe approach that gets you care in an autistic-friendly environmentWhat trauma-informed care looks like in practice Why you don't have to disclose that you're autistic, and what to say insteadGrounding techniques for exam rooms and waiting roomsNikki's book: We Deserve More: Why Health Care is Broken and What You Can Do About It The We Deserve More Workbook: A Companion for Navigating Your Reproductive HealthcareTake Back Trust: Nikki's platform for visit prep, reproductive health information, and combating medical misinformation. Find Nikki: All social media platforms at @NikkiVinckSupport the showRATED IN THE TOP 0.5% GLOBALLY with more than 1.2 million downloads!If you are an autistic person who has written a book about autism or if you have a guest suggestion email me at info@theautisticwoman.com.InstagramKo-fi, PayPal, PatreonLinktreeEmail: info@theautisticwoman.comWebsiteJune 24-28, 2026 In Rewilding Together

Recent reporting from InvestigateWest found that overcrowding in the neonatal intensive care unit at Oregon Health & Science University is raising concerns among staff and patients. Plans to expand capacity by building a new wing of OHSU’s Doernbecher Children’s Hospital have largely stalled despite rising demand for neonatal intensive care nationwide.   Dana Braner is the physician in chief at Doernbecher Children’s Hospital. He joins us to talk about the challenges hospitals are facing in providing neonatal and pregnancy care.  

Send us Fan MailWhat does it mean to truly improve outcomes for very low birth weight infants, and are we actually doing it? In this episode, Daphna sits down with Dr. Joseph Kaempf, neonatologist and Medical Director of Value Research and Innovation at Providence Health System in Oregon, to examine some uncomfortable truths about neonatal quality improvement. Dr. Kaempf shares findings from a study spanning 16 NICUs over 14 years showing that composite morbidity outcomes have remained flat while length of stay has increased. He explores why traditional QI tools like driver diagrams and PDSA cycles may no longer be sufficient, and why augmented intelligence may be the next frontier. The conversation also touches on culture as a driver of NICU performance and the gap between institutional interests and true shared decision-making with families. A candid episode for anyone invested in the future of neonatology.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Dr. Chirag Chaudhari  is an emergency medicine physician turned real estate syndicator, and the son of Indian immigrants. What began as a few rental properties with his wife has grown into a portfolio spanning nearly 800 units through hotel-to-multifamily conversions, land syndications, ground-up construction, short-term rentals, and even oil & gas funds.

In this episode of our pediatric neurology series, host Paul Wirkus, MD, FAAP and guest Josh Bonkowsky, MD explore the rapidly evolving field of gene therapy and its potential to transform the care of children with neurologic disorders. Our guest explains the science behind gene therapy, including how these treatments work to target the underlying causes of genetic disease.The conversation also examines emerging approaches to gene editing and the exciting possibilities these technologies hold for the future of pediatric medicine. Alongside the promise of these innovations, we discuss the challenges, ethical considerations, and unanswered questions that accompany this new era of precision medicine.Throughout the episode, our guest emphasizes the importance of helping patients and families understand complex treatment options so they can make informed decisions as the landscape of genetic diagnosis and therapy continues to evolve.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

What if the most disturbing conspiracy theories were never theories at all? Physician and author Dr. Juliette Engel shares her chilling journey through recovered memories of alleged MKULTRA programming, ritual abuse, and hidden intelligence operations. A haunting story of trauma, survival, and secrets buried deep within the human mind. GUEST: Dr. Juliette Engel is a physician, entrepreneur, inventor, and author of SPARKY: Surviving Sex Magick. She is known for her controversial account of surviving what she believes were childhood MKULTRA-related experiments involving psychological conditioning, dissociation, ritual abuse, and intelligence-linked programs. After decades of fragmented memories, the birth of her daughter triggered a cascade of recollections that inspired a lifelong search for answers. Today, Engel speaks publicly about trauma, memory recovery, consciousness, and what she believes are hidden systems of control operating beneath the surface of society. WEBSITE: https://julietteengel.com BOOK: SPARKY: Surviving Sex Magick FOLLOW RICHARD Website: https://www.strangeplanet.ca YouTube: @strangeplanetradio Instagram: @richardsyrettstrangeplanet TikTok: @therealstrangeplanet SUPPORT OUR SPONSORS!!! MARS MEN Mars Men helps you reclaim your edge with natural testosterone support for energy, focus, and strength Go to MenGoToMars.com right now, for a limited time, listeners of this program get 50% off for life, plus free shipping AND 3 free gifts. QUINCE Luxury, European linen that gets softer with every wash! Turn up the luxury when you turn in with Quince. Go to Quince dot com slash RSSP for free shipping on your order and 365-day returns. Now available in Canada, too. CARGURUS CarGurus is the #1 rated car shopping app in Canada on the Apple App and Google Play store. They've got hundreds of thousands of cars from top-rated dealers, plus advanced search tools that let you zero in on exactly what you want. And you can set real-time alerts for price drops and new listings — so you never miss a great deal. Buy your next car today with CarGurus at cargurus dot ca. Go to cargurus dot ca to make sure your big deal is the best deal. ⁠ BECOME A PREMIUM SUBSCRIBER!!!⁠ ⁠https://strangeplanet.supportingcast.fm⁠ Three monthly subscriptions to choose from. Commercial Free Listening, Bonus Episodes and a Subscription to my monthly newsletter, InnerSanctum. Visit ⁠https://strangeplanet.supportingcast.fm⁠ Use the discount code "Planet" to receive $5 OFF any subscription. We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and services, you agree to our use of cookies as described in our Cookie Policy. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://strangeplanet.supportingcast.fm/

Dive into the transformative power of effective parenting with Myrna Young and Dr. Josh Davis on the Transform Your Mind podcast. Dr. Davis, a neuroscientist and executive coach, shares insights from his 'Amazing Dad Program,' emphasizing the importance of mindset shifts, emotional intelligence, and practical skills. Discover how neuroscience can enhance father-child relationships and strategies for overcoming common challenges faced by fathers today. Whether you're a parent or simply interested in personal growth, this episode offers valuable tools for creating deeper connections and positive change.This episode emphasizes the transformative role fathers play using tools from neuroscience, psychology, and NLP. Dr. Davis shares insights from his groundbreaking "Amazing Dad" program, which is designed to help fathers develop critical emotional intelligence and communication skills necessary for building meaningful family relationships.Delving deeper into the intersection of neuroscience and parenting, this episode unravels the concept of being an “amazing” dad versus a “perfect” dad, effective Parenting through pacing and leading techniques. How to manage parental anger and emotional regulation and highlights the importance of intentionality and connection over unattainable perfection. Dr. Davis explains how small yet consistent changes in behavior and mindset can significantly impact family dynamics and individual growth. Through engaging discourse, the episode provides actionable strategies for reprogramming parenting mindsets. This episode promises to be a valuable resource for fathers, parents, and anyone interested in strengthening personal relationships through the lens of cognitive science.Timestamp Summary0:02 Empowering Fathers Through Neuroscience and Emotional Intelligence2:42 Empowering Dads with Tools for Modern Parenting Challenges7:57 Balancing Fatherhood and Career for Meaningful Relationships10:09 Redefining Fatherhood: From Perfection to Being Amazing14:37 Understanding Behavior Through Neuro Linguistic Programming16:39 Reprogramming Dads: Using NLP for Positive Behavioral Change23:07 Effective Parenting Through Pacing and Leading Techniques27:15 Navigating Authority and Influence in Parent-Child Relationships34:11 Managing Parental Anger and Emotional Regulation at Dinner Time38:30 The Power of Third-Party Perspective in Emotional Situations40:23 Reprogramming Parenting Mindsets to Manage Children's Eating Habits44:35 Empowering Dads Through Neuroscience and Personal GrowthResources:Josh Davis, PhD - Official WebsiteSocial Media: Search JoshDavisPhD on YouTube, TikTok, Instagram, Facebook, and LinkedIn for more insights.Book: The Difference That Makes the Difference: NLP and the Science of Positive ChangeSponsors of this podcastWith Wegovy at Hers, lose up to 20% or more of your body weight when combined with diet and exercise.  Visit forhers.com/transform to get personalized, affordable care that gets you. Physicians Choice: Better health really does start in the gut. Physician's Choice 60 Billion Probiotic Go to Amazon or physicianschoice.com and use code PCPODCAST10 for 10% off your entire order. See this video on The Transform Your Mind YouTube Channel https://www.youtube.com/@MyhelpsUs/videosTo see a transcripts of this audio as well as links to all the advertisers on the show page https://myhelps.us/Follow Transform Your Mind on Instagram https://www.instagram.com/myrnamyoung/Follow Transform Your mind on Facebookhttps://www.facebook.com/profile.php?id=100063738390977Please leave a rating and review on iTunes https://podcasts.apple.com/us/podcast/transform-your-mind/id1144973094Feedspot Top 100 Mental Health Podcast For sponsored Brand interviews and sponsorship inquires please visit Partner With The Transform Your Mind Podcast | Myrna Young Life Coach